BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• BioMidwest

  RSNA Release: Migraines Linked to High Sodium Levels in Cerebrospinal Fluid

  Migraine sufferers have significantly higher sodium concentrations in their cerebrospinal fluid than people without the condition, according to the first study to use a technique called sodium MRI to look at migraine patients.

  November 28, 2017

   · 

  3 min read
• Policy

  Kyowa Hakko Kirin Announces FDA Acceptance for Filing and Priority Review Designation of Mogamulizumab’s Biologics License Application

  This BLA is supported by the data from the MAVORIC study, the largest global randomized clinical trial of systemic therapy in CTCL.

  November 28, 2017

   · 

  2 min read
• 

  Drug Development

  Egalet Surges as Back Pain Drug Meets Goals in Phase III Trial

  The study met its primary endpoint, which showed a statistically significant difference in average pain intensity from baseline to week 16 between the Egalet-002 and placebo treatment groups.

  November 28, 2017

   · 

  6 min read
• 

  Business

  Bay Area’s Ardelyx Nabs $160M Deal With Kyowa Hakko Kirin

  Ardelyx will receive a $30 million upfront payment and is eligible to receive additional development and commercialization milestones worth up to $130 million.

  November 28, 2017

   · 

  5 min read
• Pharm Country

  Dynamk Capital Invests in Envisagenics to Advance AI Drug Discovery

  Dynamk Capital invested $500,000 in Envisagenics, leading the $2.25M seed round alongside other investors.

  November 28, 2017

   · 

  3 min read
• Business

  Synpromics Announces Collaboration With UCL to Develop Revolutionary Gene Therapy for Parkinson’s Disease

  The joint project will see the company develop novel gene promoters that specifically control the expression of therapeutic genes in different sub-populations of neurones.

  November 28, 2017

   · 

  3 min read
• BioMidwest

  RSNA Release: Fat Distribution in Women and Men Provides Clues to Heart Attack Risk

  The study looked at the differences in fat distribution patterns among overweight and obese men and women and their associated cardiometabolic risk.

  November 28, 2017

   · 

  4 min read
• Biotech Beach

  Kurin Receives Allowance from United States Patent and Trademark Office for Patent on Innovative Blood Culture Collection Device

  The Kurin blood culture collection set is a replacement for traditional collection sets, introducing technology to divert skin contaminants while preserving the standard blood culture collection technique for clinicians.

  November 28, 2017

   · 

  2 min read
• Business

  Biomillenia Leverages QIAGEN Bioinformatics in Microbiome-on-a-Chip Discovery of Unculturable Microbes

  Biomillenia’s approach is able to identify strains of microbes previously deemed unculturable, and at unprecedented speeds.

  November 28, 2017

   · 

  3 min read
• Business

  Achieve Announces Clinical Trial Supply and Cooperation Agreement With the University of Auckland for the Evaluation of Cytisine Compared to Varenicline for Smoking Cessation

  Achieve Life Science today announced an agreement with Auckland UniServices Limited, as the commercial arm of the University of Auckland, to provide cytisine for use in the Phase 3 “RAUORA” clinical trial.

  November 28, 2017

   · 

  5 min read